Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement

The ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) are the two most important cellular mechanisms for protein degradation. To investigate the role of autophagy in reversing neuronal injury, the proteasome inhibitor lactacystin was used to cause UPS dysfunction in differentiated PC12 cells and in C57BL/6 mice and rapamycin was used as an autophagy enhancer. The results showed that rapamycin pre-treatment attenuated lactacystin-induced apoptosis and reduced lactacystin-induced ubiquitinated protein aggregation in differentiated PC12 cells. The observed protection was partially blocked by the autophagy inhibitor 3-methyladenine. Furthermore, post-treatment of mice with rapamycin significantly attenuated lactacystin-induced loss of nigral DA neurons and the reduction of striatal DA levels. The lactacystin-induced high molecular ubiquitinated proteins were also attenuated by rapamycin treatment in vivo. In addition, as a chemical compound, rapamycin caused an increase of bcl2 protein level and blocked the release of cytochrome c from mitochondria to cytosal. We concluded that the neuroprotective effect of rapamycin is partially mediated by autophagy enhancement through enhanced degradation of misfolded proteins and autophagy enhancement may be considered to be a promising strategy to prevent diseases associated with misfolded/aggregated proteins, such as Parkinson's disease.

[1]  B. Aggarwal,et al.  Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways , 2007, Molecular Pharmacology.

[2]  U. Lopes,et al.  p53-dependent Induction of Apoptosis by Proteasome Inhibitors* , 1997, The Journal of Biological Chemistry.

[3]  A. Tolkovsky,et al.  Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? , 2002, Biochimie.

[4]  D. Rubinsztein,et al.  The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.

[5]  A. Cuervo,et al.  Oxidative stress and autophagy. , 2006, Antioxidants & redox signaling.

[6]  S. Appel,et al.  Use of [3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. , 1992, Brain research. Developmental brain research.

[7]  Leonidas Stefanis,et al.  Involvement of macroautophagy in the dissolution of neuronal inclusions. , 2004, The international journal of biochemistry & cell biology.

[8]  Brian Spencer,et al.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.

[9]  Rainer Duden,et al.  Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. , 2002, Human molecular genetics.

[10]  Zheng‐gang Liu,et al.  Autophagy plays a protective role during zVAD-induced necrotic cell death , 2008, Autophagy.

[11]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[12]  Philippe Dessen,et al.  Inhibition of Macroautophagy Triggers Apoptosis , 2005, Molecular and Cellular Biology.

[13]  Vidya N. Nukala,et al.  Characterization of chronic low‐level proteasome inhibition on neural homeostasis , 2003, Journal of neurochemistry.

[14]  S. Emr,et al.  Autophagy as a regulated pathway of cellular degradation. , 2000, Science.

[15]  A. Cuervo,et al.  Autophagy and neurodegeneration: when the cleaning crew goes on strike , 2007, The Lancet Neurology.

[16]  Arnold J. Levine,et al.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Tianhong Pan,et al.  Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. , 2005, Biochemical and biophysical research communications.

[18]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[19]  R. Kopito,et al.  HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin* , 2005, Journal of Biological Chemistry.

[20]  Claudio Soto,et al.  Protein misfolding and neurodegeneration. , 2008, Archives of neurology.

[21]  Takeshi Tokuhisa,et al.  The role of autophagy during the early neonatal starvation period , 2004, Nature.

[22]  T. Sherer,et al.  Ubiquitin–proteasome system and Parkinson's diseases , 2005, Experimental Neurology.

[23]  R. S. Sohal,et al.  Mechanisms of aging: an appraisal of the oxidative stress hypothesis. , 2002, Free radical biology & medicine.

[24]  D. Rubinsztein,et al.  Rapamycin pre-treatment protects against apoptosis. , 2006, Human molecular genetics.

[25]  E. Ongini,et al.  Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression , 2000, Neuropharmacology.

[26]  J. Lemasters.  Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. , 2005, Rejuvenation research.

[27]  A. Majid,et al.  The mTOR pathway as a potential target for the development of therapies against neurological disease. , 2007, Drug news & perspectives.

[28]  Y. Kondo,et al.  Pivotal Role of the Cell Death Factor BNIP3 in Ceramide-Induced Autophagic Cell Death in Malignant Glioma Cells , 2004, Cancer Research.

[29]  C. Olanow,et al.  Ubiquitin–proteasome system and Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[30]  G. Mills,et al.  Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. , 2005, Cancer research.

[31]  G. Mills,et al.  Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells , 2007, Oncogene.

[32]  U. Brunk,et al.  The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. , 2002, European journal of biochemistry.

[33]  D. Sulzer,et al.  Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells , 2001, Journal of neurochemistry.

[34]  L. Stefanis,et al.  Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2 , 2005, Apoptosis.

[35]  E. Shohami,et al.  Rapamycin is a neuroprotective treatment for traumatic brain injury , 2007, Neurobiology of Disease.

[36]  J. Jankovic,et al.  Prevention and restoration of lactacystin‐induced nigrostriatal dopamine neuron degeneration by novel brain‐permeable iron chelators , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  C. Olanow,et al.  Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures , 2002, Journal of neurochemistry.

[38]  A. Asai,et al.  Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons , 2000, The Journal of Neuroscience.

[39]  Leonidas Stefanis,et al.  Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway , 2004, Journal of neurochemistry.

[40]  C. Olanow,et al.  Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease , 2006, Neurobiology of Aging.

[41]  J. Keller,et al.  Dopamine induces proteasome inhibition in neural PC12 cell line. , 2000, Free radical biology & medicine.

[42]  Hideyuki Okano,et al.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice , 2006, Nature.

[43]  G. Guidotti,et al.  Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis , 2005, Cell Death and Differentiation.

[44]  Masaaki Komatsu,et al.  Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.

[45]  Tianhong Pan,et al.  The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.

[46]  Hiroshi Shibasaki,et al.  Proteasome Mediates Dopaminergic Neuronal Degeneration, and Its Inhibition Causes α-Synuclein Inclusions* , 2004, Journal of Biological Chemistry.

[47]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[48]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[49]  Masaaki Komatsu,et al.  Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.

[50]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[51]  Dan Garza,et al.  HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS , 2007, Nature.

[52]  A. Cuervo,et al.  Consequences of the selective blockage of chaperone-mediated autophagy. , 2006, Proceedings of the National Academy of Sciences of the United States of America.